Safety test of MODI insulin adjustment system for adults
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This trial tests MODI, a smartphone app that helps automatically adjust your insulin doses based on blood sugar readings from a continuous glucose monitor. The study checks if this system is safe and helps people with type 1 or type 2 diabetes manage their blood sugar better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have type 1 or type 2 diabetes diagnosed at least 6 months ago
- You take insulin by injection (at least one basal insulin shot daily) and have been on a stable insulin routine for at least 3 months
- Your blood sugar level (HbA1c) is between 7.5% and 12% at screening
- You are between 18 and 80 years old and weigh between 80 and 440 pounds
- You have a smartphone (iPhone with iOS 17+ or Android 10+) and agree to use a continuous glucose monitor (FSL 3 System) and study app daily
- You have not had an insulin pump, severe low blood sugar events, or diabetic emergencies in the past 3–6 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a smart insulin pump and continuous glucose monitor system that adjusts insulin automatically and uses behavior support to improve blood sugar control. It's for people with type 1 diabetes who have used an approved automated insulin delivery system recently and are willing to use study devices.
This study tests an app-based diabetes education program for people with type 1 diabetes. It aims to see if the app can help you manage your blood sugar levels better using insulin pens and a continuous glucose monitor.
This study looks at whether turning off meal announcements in automated insulin delivery systems (which adjust insulin automatically) is safe and effective for people with type 1 diabetes. It may help simplify daily diabetes management.
This study tests an “artificial pancreas” system that automatically helps control insulin to reduce wide swings in blood sugar. It also aims to see whether steadier sugars can improve heart health in adults with type 1 diabetes.
This trial studies a smartphone system that helps people with diabetes decide how much insulin to take. It is for people who use insulin injections or are starting basal insulin, and it uses a continuous glucose monitor to guide dosing.
This study tests a system that measures blood sugar and automatically adjusts insulin delivery. It is for adults with type 1 diabetes who use insulin injections or a pump.
Hear when a new Type 1 Diabetes (T1D) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.